We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by ...

Batch management plays a crucial role in the life sciences industry, ensuring quality, compliance, and traceability. Learn ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

IN AN EFFORT to produce graduates with chemical engineering and chemistry skillsets, Nanyang Technological University (NTU) ...

In the increasingly complex healthcare realm, a regular flow of drug introductions offers potential ... A collaborative drug ...

Hypera S.A. Sponsored ADR ( (HYPMY) ) has released its Q3 earnings. Here is a breakdown of the information Hypera S.A. Sponsored ADR presented ...

Lilly filed a lawsuit Nov. 14 against HHS head Xavier Becerra and the Health Resources and Services Administration for blocking a plan to change its 340B program from immediate discounts to offering ...

US Retail Sales beat forecasts, but still grew by a smaller amount in October.

More than a few companies that did well in the past are out of favor with investors. And that could spell opportunity.

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

Q3 2024 Results Earnings Conference Call November 13, 2024 4:30 PM ET. Company Participants. William Febbo - Chief Executive Officer Edward St ...